Local Study of Akatinol Memantine in VaD in Russia

Clinical trial NCT03986424 · COMPLETED

Trial details

NCT number: NCT03986424
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vascular Dementia

Start date: 2018-01-23
Primary completion: 2022-06-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.